Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Dec 24, 2024, 3:00 PM EST
Oncotelic Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -4.66 | -7.9 | 5.09 | -9.39 | -9.5 | -6.64 | Upgrade
|
| Depreciation & Amortization | - | - | 0.01 | 0.06 | 0.36 | 0.06 | Upgrade
|
| Other Amortization | 0.42 | 0.3 | 1.98 | 1.45 | 1.32 | 0.75 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.2 | 6.08 | -12.84 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.01 | -0.01 | - | - | - | 1.77 | Upgrade
|
| Stock-Based Compensation | - | - | 0.9 | 1.18 | 2.15 | 0.76 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 0 | - | - | - | - | Upgrade
|
| Other Operating Activities | 0.17 | 0.3 | 2.6 | 1.95 | 2.32 | -0.07 | Upgrade
|
| Change in Accounts Payable | -0.14 | -0.05 | 0.8 | 0.22 | 0.47 | 1.17 | Upgrade
|
| Change in Other Net Operating Assets | 0.01 | -0.04 | -0 | 0.08 | 0.07 | -0.08 | Upgrade
|
| Operating Cash Flow | -1.01 | -1.32 | -1.45 | -4.43 | -2.81 | -2.28 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.19 | Upgrade
|
| Investing Cash Flow | - | - | - | - | - | 0.19 | Upgrade
|
| Short-Term Debt Issued | - | 1.41 | 0.97 | 3.07 | 0.35 | 2.09 | Upgrade
|
| Total Debt Issued | 0.92 | 1.41 | 0.97 | 3.07 | 0.35 | 2.09 | Upgrade
|
| Short-Term Debt Repaid | - | -0.04 | - | -0.5 | -0.05 | - | Upgrade
|
| Total Debt Repaid | - | -0.04 | - | -0.5 | -0.05 | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.92 | 1.38 | 0.97 | 2.56 | 0.3 | 2.09 | Upgrade
|
| Issuance of Common Stock | - | - | 0.16 | 1.97 | 2.93 | 0.08 | Upgrade
|
| Other Financing Activities | -0.03 | -0.13 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 0.89 | 1.25 | 1.13 | 4.53 | 3.22 | 2.17 | Upgrade
|
| Net Cash Flow | -0.12 | -0.07 | -0.33 | 0.09 | 0.41 | 0.08 | Upgrade
|
| Free Cash Flow | -1.01 | -1.32 | -1.45 | -4.43 | -2.81 | -2.28 | Upgrade
|
| Free Cash Flow Margin | - | -1887.21% | - | - | -161.53% | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.03 | -0.04 | Upgrade
|
| Cash Interest Paid | 0.38 | 0.39 | 0.4 | 0.3 | 0.05 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0 | - | Upgrade
|
| Levered Free Cash Flow | -0.31 | -0.58 | -3.27 | -4.24 | -1.4 | 3.75 | Upgrade
|
| Unlevered Free Cash Flow | -0.19 | -0.23 | -3.39 | -4.44 | -1.47 | 3.47 | Upgrade
|
| Change in Net Working Capital | -0.1 | -0.12 | 0.8 | -0.02 | -0.76 | -5.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.